相似文献
1
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
J Neurol Neurosurg Psychiatry. 1985 May;48(5):469-71. doi: 10.1136/jnnp.48.5.469.
2
3
Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
J Neurol Sci. 1996 Sep 15;141(1-2):39-44. doi: 10.1016/0022-510x(96)00115-3.
4
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
Alzheimers Dement. 2013 Sep;9(5):488-98. doi: 10.1016/j.jalz.2012.06.010. Epub 2012 Nov 14.
5
6
[Features of neurotransmitter pool in cerebrospinal fluid of patients with epilepsy].
Zh Nevrol Psikhiatr Im S S Korsakova. 2001;101(6):39-41.
7
Use of high performance liquid chromatography in defining the abnormalities in the free amino acid patterns in the cerebrospinal fluid of patients with aseptic meningitis.
Biomed Chromatogr. 1991 Sep;5(5):216-20. doi: 10.1002/bmc.1130050508.
8
Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease.
J Neural Transm (Vienna). 1998;105(2-3):269-77. doi: 10.1007/s007020050056.
9
Glutamate and other CSF amino acids in Alzheimer's disease.
Am J Psychiatry. 1992 Feb;149(2):251-4. doi: 10.1176/ajp.149.2.251.
10
Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy.
Epilepsia. 1993 Mar-Apr;34(2):255-61. doi: 10.1111/j.1528-1157.1993.tb02407.x.
引用本文的文献
1
Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis.
BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.
2
Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy.
Metabolites. 2023 Mar 1;13(3):369. doi: 10.3390/metabo13030369.
3
Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?
Transl Psychiatry. 2022 Jun 22;12(1):257. doi: 10.1038/s41398-022-02024-7.
4
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.
Amino Acids. 2021 Mar;53(3):435-449. doi: 10.1007/s00726-021-02943-7. Epub 2021 Feb 22.
5
Altered Brain Metabolome Is Associated with Memory Impairment in the rTg4510 Mouse Model of Tauopathy.
Metabolites. 2020 Feb 14;10(2):69. doi: 10.3390/metabo10020069.
6
Association between Brain and Plasma Glutamine Levels in Healthy Young Subjects Investigated by MRS and LC/MS.
Nutrients. 2019 Jul 19;11(7):1649. doi: 10.3390/nu11071649.
7
Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression.
Front Psychiatry. 2018 Nov 6;9:561. doi: 10.3389/fpsyt.2018.00561. eCollection 2018.
8
Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.
Dement Geriatr Cogn Dis Extra. 2017 May 4;7(1):143-159. doi: 10.1159/000466688. eCollection 2017 Jan-Apr.
9
Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
J Alzheimers Dis. 2017;57(4):1071-1086. doi: 10.3233/JAD-160702.
10
Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
Transl Psychiatry. 2016 Mar 1;6(3):e744. doi: 10.1038/tp.2016.8.
本文引用的文献
1
The token test: A sensitive test to detect receptive disturbances in aphasics.
Brain. 1962 Dec;85:665-78. doi: 10.1093/brain/85.4.665.
2
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain.
J Neurochem. 1980 Jan;34(1):43-9. doi: 10.1111/j.1471-4159.1980.tb04619.x.
3
Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.
Neurosci Lett. 1984 Jan 27;44(1):47-51. doi: 10.1016/0304-3940(84)90219-2.
4
Dementia in epilepsy.
Acta Neurol Scand Suppl. 1984;99:99-104.
5
Calcium in long-term potentiation as a model for memory.
Neuroscience. 1983 Dec;10(4):1071-81. doi: 10.1016/0306-4522(83)90100-8.
6
The evoked release of endogenous amino acids from tissue prisms of human neocortex.
Brain Res. 1983 Jun 13;269(1):103-9. doi: 10.1016/0006-8993(83)90966-6.
7
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
J Neurochem. 1983 Jul;41(1):266-72. doi: 10.1111/j.1471-4159.1983.tb11838.x.
8
The biochemistry of memory: a new and specific hypothesis.
Science. 1984 Jun 8;224(4653):1057-63. doi: 10.1126/science.6144182.
9
Neurochemical characteristics of early and late onset types of Alzheimer's disease.
Br Med J (Clin Res Ed). 1984 Mar 31;288(6422):961-4. doi: 10.1136/bmj.288.6422.961.
10
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.
Brain Res. 1983 Mar 28;264(1):138-41. doi: 10.1016/0006-8993(83)91131-9.
Zotero 插件